Bio-Rad Laboratories Inc (BIO) - Pharmaceuticals and Healthcare - Deals and Alliances Profile

Summary

Bio-Rad Laboratories Inc (Bio-Rad) develops, manufactures and markets a range of products and systems for the life science research, healthcare, analytical chemistry and other markets. The companys major products include reagents, apparatus, laboratory instruments, test systems, informatics systems, test kits and specialized quality controls. Bio-Rad offers its products to universities and medical schools, industrial research organizations, pharmaceutical manufacturers, government agencies, biotechnology researchers, food producers, food testing laboratories, reference laboratories, hospital and transfusion laboratories, and physician office laboratories. The company offers its products through direct sales force and also through a network of distributors, agents, brokers and resellers across the world. The company operates in the US, Canada, Latin America, Europe and Pacific Rim, among others. Bio-Rad is headquartered in California, the US.

Bio-Rad Laboratories Inc (BIO) - Pharmaceuticals & Healthcare - Deals and Alliances Profile provides you comprehensive data and trend analysis of the companys Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

It derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals - Analysis of the companys financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year - Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type - Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region - Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector - Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals - Information on the companys major financial deals. Each such deal has a brief Summary, deal type, deal rationale; and deal financials and target Companys (major public companies) key financial metrics and ratios.
- Business Description - A brief description of the companys operations.
- Key Employees - A list of the key executives of the company.
- Important Locations and Subsidiaries - A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors - A list of the key competitors of the company.
- Key Recent Developments - A brief on recent news about the company.

Reasons to Buy

Get detailed information on the companys financial deals that enable you to understand the companys expansion/divestiture and fund requirements
- The profile enables you to analyze the companys financial deals by region, by year, by business segments and by type, for a five year period.

Understand the companys business segments expansion / divestiture strategy
- The profile presents deals from the companys core business segments perspective to help you understand its corporate strategy.

Access elaborate information on the companys recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a Summary of each deal, deal type, deal rationale, deal financials and Target Companys key financial metrics and ratios.

Equip yourself with detailed information about the companys operations to identify potential customers and suppliers.
- The profile analyzes the companys business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.



List of Tables 5
List of Figures 5
Bio-Rad Laboratories Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 6
Bio-Rad Laboratories Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 7
Bio-Rad Laboratories Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 8
Bio-Rad Laboratories Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 9
Bio-Rad Laboratories Inc, Medical Devices Deals, 2012 to YTD 2018 10
Bio-Rad Laboratories Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 11
Bio-Rad Laboratories Inc, Pharmaceuticals & Healthcare, Deal Details 13
Venture Financing 13
RainDance Technologies Raises US$16.5 Million In Extended Series E Financing 13
RainDance Technologies Raises US$35 Million In Venture Financing 14
RainDance Technologies Raises US$20 Million In Series E Financing 15
GnuBio Raises US$10 Million In Series B Financing 16
Partnerships 17
AbD Serotec Enters Into Licensing Agreement With DiaSorin For HuCAL Antibodies 17
Genetic Analysis Enters into Agreement with Bio-Rad Labs 18
Bio-Rad Laboratories Enters into Partnership with Illumina 19
Pacific Biosciences Enters into Co-Development and Co-Marketing Agreement with RainDance Technologies 20
RainDance Technologies Enters Into Co-Development Agreement With Integrated DNA Technologies For Digital PCR 21
RainDance Technologies Enters Into Co-Development Agreement With MLL Munchner Leukamie Labor 22
RainDance Technologies Enters Into Co-Development Agreement With Sony DADC Austria 23
Licensing Agreements 24
Vegenics Enters into Licensing Agreement with Bio-Rad Labs 24
Acquisition 25
Bio-Rad Labs Acquires RainDance Technologies 25
Bio-Rad Labs Acquires GnuBio, DNA Sequencing Technology Company 26
Bio-Rad Labs Completes Acquisition Of AbD Serotec From MorphoSys 27
Bio-Rad Laboratories Inc - Key Competitors 28
Bio-Rad Laboratories Inc - Key Employees 29
Bio-Rad Laboratories Inc - Locations And Subsidiaries 30
Head Office 30
Other Locations & Subsidiaries 30
Recent Developments 33
Financial Announcements 33
May 08, 2018: Bio-Rad Announces First Quarter 2018 Financial Results 33
Feb 27, 2018: Bio-Rad Reports Fourth-Quarter and Full-Year 2017 Financial Results 34
Nov 02, 2017: Bio-Rad Reports Third-Quarter 2017 Financial Results 36
Aug 03, 2017: Bio-Rad Reports Second-Quarter 2017 Financial Results 37
May 04, 2017: Bio-Rad Reports First-Quarter 2017 Financial Results 38
Mar 13, 2017: Bio-Rad Initiates Long Term Financial Guidance; Commits to Defining Long Term Capital Allocation Targets and Hosting an Annual Investor Day 39
Feb 23, 2017: VBio-Rad Reports Fourth-Quarter and Full-Year 2016 Financial Results 40
Feb 23, 2017: Bio-Rad Reports Fourth-Quarter and Full-Year 2016 Financial Results 42
Corporate Communications 44
Mar 13, 2017: Bio-Rad Intends to Propose Three New Independent Directors 44
Product News 45
Dec 04, 2017: Bio-Rad Releases First CE-IVD Digital PCR Test for Monitoring Chronic Myeloid Leukemia Response to Therapy 45
May 09, 2018: Bio-Rad Releases Labeled Antibodies for Fluorescent Multiplex Detection of Proteins in Western Blots 46
May 01, 2017: Bio-Rad Expands Its Multiplex Immunoassays with the Launch of Bio-Plex Pro Human Apolipoprotein Panel 47
Apr 19, 2017: Bio-Rad Releases Labeled Antibodies for Fluorescent Multiplex Detection of Proteins in Western Blots 48
Jan 09, 2017: Illumina and Bio-Rad Launch Solution for Single-Cell Genomic Sequencing to Enable Robust Study of Complex Diseases 49
Jan 08, 2018: Bio-Rad Launches NGC Fraction Collector for NGC Chromatography Systems 50
Appendix 51
Methodology 51
About GlobalData 51
Contact Us 51
Disclaimer 51

List Of Tables

List of Tables
Bio-Rad Laboratories Inc, Pharmaceuticals & Healthcare, Key Facts, 2017 2
Bio-Rad Laboratories Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 6
Bio-Rad Laboratories Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 7
Bio-Rad Laboratories Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 8
Bio-Rad Laboratories Inc, Deals By Therapy Area, 2012 to YTD 2018 9
Bio-Rad Laboratories Inc, Medical Devices Deals, 2012 to YTD 2018 10
Bio-Rad Laboratories Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 11
RainDance Technologies Raises US$16.5 Million In Extended Series E Financing 13
RainDance Technologies Raises US$35 Million In Venture Financing 14
RainDance Technologies Raises US$20 Million In Series E Financing 15
GnuBio Raises US$10 Million In Series B Financing 16
AbD Serotec Enters Into Licensing Agreement With DiaSorin For HuCAL Antibodies 17
Genetic Analysis Enters into Agreement with Bio-Rad Labs 18
Bio-Rad Laboratories Enters into Partnership with Illumina 19
Pacific Biosciences Enters into Co-Development and Co-Marketing Agreement with RainDance Technologies 20
RainDance Technologies Enters Into Co-Development Agreement With Integrated DNA Technologies For Digital PCR 21
RainDance Technologies Enters Into Co-Development Agreement With MLL Munchner Leukamie Labor 22
RainDance Technologies Enters Into Co-Development Agreement With Sony DADC Austria 23
Vegenics Enters into Licensing Agreement with Bio-Rad Labs 24
Bio-Rad Labs Acquires RainDance Technologies 25
Bio-Rad Labs Acquires GnuBio, DNA Sequencing Technology Company 26
Bio-Rad Labs Completes Acquisition Of AbD Serotec From MorphoSys 27
Bio-Rad Laboratories Inc, Key Competitors 28
Bio-Rad Laboratories Inc, Key Employees 29
Bio-Rad Laboratories Inc, Subsidiaries 30

List Of Figures

List of Figures
Bio-Rad Laboratories Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
Bio-Rad Laboratories Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
Bio-Rad Laboratories Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
Bio-Rad Laboratories Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
Bio-Rad Laboratories Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 6
Bio-Rad Laboratories Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 7
Bio-Rad Laboratories Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 8
Bio-Rad Laboratories Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 9
Bio-Rad Laboratories Inc, Medical Devices Deals, 2012 to YTD 2018 10

Musculoskeletal Disorders Drugs Global Market Forecast To 2022 Including: Drugs For Rheumatoid Arthritis, Muscle Relaxants, Others - Musculoskeletal Disorders Drugs Covering: F. Hoffmann-La Roche Ltd, GlaxosmithKline Plc, Pfizer Inc, Abbott Laboratories Inc, Daiichi Sankyo Company

The musculoskeletal disorders drugs market consists of sales of musculoskeletal disorders drugs and related services by entities (organizations, sole traders and partnerships) that produce musculoskeletal disorders drugs to treat musculoskeletal

USD 4000 View Report

Fill The Form For Sample Request

Note : * Kindly provide us with your company id and get the sample reports at the earliest.

There is no Reviews available